Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endocrine pharmacology of antiestrogens as antitumor agents.

× No keyword cloud information.

49 in total

Review 1. Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.

Authors: Pedro N Batalha; Luana S M Forezi; Carolina G S Lima; Fernanda P Pauli; Fernanda C S Boechat; Maria Cecília B V de Souza; Anna C Cunha; Vitor F Ferreira; Fernando de C da Silva
Journal: Bioorg Chem Date: 2020-11-19 Impact factor: 5.275

Review 2. Transcription factors as drug targets: opportunities for therapeutic selectivity.

Authors: T R Butt; S K Karathanasis
Journal: Gene Expr Date: 1995

3. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells.

Authors: T van Agthoven; T L van Agthoven; A Dekker; P J van der Spek; L Vreede; L C Dorssers
Journal: EMBO J Date: 1998-05-15 Impact factor: 11.598

Review 4. Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.

Authors: H M Bryson; G L Plosker
Journal: Pharmacoeconomics Date: 1993-07 Impact factor: 4.981

5. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens.

Authors: M M Montano; K Ekena; R Delage-Mourroux; W Chang; P Martini; B S Katzenellenbogen
Journal: Proc Natl Acad Sci U S A Date: 1999-06-08 Impact factor: 11.205

6. The effects of intermittent progesterone upon tamoxifen inhibition of tumor growth in the 7,12-dimethylbenzanthracene rat mammary tumor model.

Authors: D F Gibson; D A Johnson; S M Langan-Fahey; M K Lababidi; W H Wolberg; V C Jordan
Journal: Breast Cancer Res Treat Date: 1993-09 Impact factor: 4.872

7. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.

Authors: A Mahfoudi; E Roulet; S Dauvois; M G Parker; W Wahli
Journal: Proc Natl Acad Sci U S A Date: 1995-05-09 Impact factor: 11.205

8. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors: P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal: Proc Natl Acad Sci U S A Date: 1996-09-17 Impact factor: 11.205

9. Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin.

Authors: Kevin Shoulars; Mary Ann Rodriguez; Trellis Thompson; Barry M Markaverich
Journal: J Steroid Biochem Mol Biol Date: 2009-10-27 Impact factor: 4.292

10. Effects of tamoxifen on GH and IGF-I levels in acromegaly.

Authors: R Cozzi; R Attanasio; G Oppizzi; P Orlandi; A Giustina; S Lodrini; N Da Re; D Dallabonzana
Journal: J Endocrinol Invest Date: 1997-09 Impact factor: 4.256